搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 2 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Japanese activists urge all sectors in Japan to face up history
Bastillepost· 3 日前During the process of collecting testimonies, Matsuoka was deeply touched and shocked by the ...
On tour in Europe with the Hong Kong Philharmonic Orchestra
South China Morning Post· 3 日前This European tour, the longest in the orchestra’s history, was now being billed as part of its ...
Sexual harassment allegations against LGBTQ-friendly pastor in Hong Kong raise questions over ...
Hong Kong Free Press· 4 日前In a February statement, the church said Pang had committed “serious misconduct” and ...
Antonio Nusa: Why Chelsea and Tottenham are interested in the 'Norwegian Neymar' | ...
Goal.com· 5 日前For various reasons, the 2024 January transfer window was the quietest in recent memory. One su ...
UK nuclear power strategy takes shape
Reuters· 6 日前Last month, British Prime Minister Rishi Sunak declared that securing the future of the ...